BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 27115956)

  • 1. Alpha-1 Antitrypsin Therapy in Cystic Fibrosis and the Lung Disease Associated with Alpha-1 Antitrypsin Deficiency.
    McElvaney NG
    Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S191-6. PubMed ID: 27115956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of Alpha-1 Antitrypsin to Airways.
    Griese M; Scheuch G
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S346-51. PubMed ID: 27564672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-1 antitrypsin augmentation therapy.
    Wewers MD; Crystal RG
    COPD; 2013 Mar; 10 Suppl 1():64-7. PubMed ID: 23527997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aralast: an alpha 1-protease inhibitor for the treatment of alpha-antitrypsin deficiency.
    Mordwinkin NM; Louie SG
    Expert Opin Pharmacother; 2007 Oct; 8(15):2609-14. PubMed ID: 17931094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serine proteinase inhibitor therapy in alpha(1)-antitrypsin inhibitor deficiency and cystic fibrosis.
    Döring G
    Pediatr Pulmonol; 1999 Nov; 28(5):363-75. PubMed ID: 10536068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients.
    Griese M; Latzin P; Kappler M; Weckerle K; Heinzlmaier T; Bernhardt T; Hartl D
    Eur Respir J; 2007 Feb; 29(2):240-50. PubMed ID: 17050563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis.
    Martin SL; Downey D; Bilton D; Keogan MT; Edgar J; Elborn JS;
    Pediatr Pulmonol; 2006 Feb; 41(2):177-83. PubMed ID: 16372352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerosol alpha 1-antitrypsin treatment for cystic fibrosis.
    McElvaney NG; Hubbard RC; Birrer P; Chernick MS; Caplan DB; Frank MM; Crystal RG
    Lancet; 1991 Feb; 337(8738):392-4. PubMed ID: 1671425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil elastase-mediated lung disease.
    Sandhaus RA; Turino G
    COPD; 2013 Mar; 10 Suppl 1():60-3. PubMed ID: 23527919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-1 antitrypsin augmentation therapy corrects accelerated neutrophil apoptosis in deficient individuals.
    Hurley K; Lacey N; O'Dwyer CA; Bergin DA; McElvaney OJ; O'Brien ME; McElvaney OF; Reeves EP; McElvaney NG
    J Immunol; 2014 Oct; 193(8):3978-91. PubMed ID: 25217166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for aerosol therapy of alpha 1-antitrypsin deficiency by the aerosol route.
    Hubbard RC; Crystal RG
    Lung; 1990; 168 Suppl():565-78. PubMed ID: 2117165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B4 Neutrophil Signaling.
    O'Dwyer CA; O'Brien ME; Wormald MR; White MM; Banville N; Hurley K; McCarthy C; McElvaney NG; Reeves EP
    J Immunol; 2015 Oct; 195(8):3628-41. PubMed ID: 26371243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.
    Chiuchiolo MJ; Crystal RG
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4(Suppl 4):S352-69. PubMed ID: 27564673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of α1-antitrypsin deficiency.
    Stoller JK; Aboussouan LS
    Am J Respir Crit Care Med; 2012 Feb; 185(3):246-59. PubMed ID: 21960536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature.
    Parr DG; Lara B
    Drug Des Devel Ther; 2017; 11():2149-2162. PubMed ID: 28769553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of lung diseases with antiproteases].
    Vogelmeier C; Buhl R
    Pneumologie; 1994 Feb; 48(2):57-62. PubMed ID: 7910401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Historical role of alpha-1-antitrypsin deficiency in respiratory and hepatic complications.
    Zuo L; Pannell BK; Zhou T; Chuang CC
    Gene; 2016 Sep; 589(2):118-22. PubMed ID: 26768576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in neutrophil elastase concentration by recombinant alphal-antitrypsin (recAAT) does not alter bacterial loading in the sputum of cystic fibrosis patients.
    Moore JE; Shaw A; Millar BC; Martin SL; Murphy PG; Downey DG; Ennis M; Elborn JS
    Br J Biomed Sci; 2004; 61(3):146-7. PubMed ID: 15462261
    [No Abstract]   [Full Text] [Related]  

  • 19. Alpha-1 antitrypsin: now available, but do we need it?
    Russi EW
    Swiss Med Wkly; 2008 Apr; 138(13-14):191-6. PubMed ID: 18389391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase.
    Jonigk D; Al-Omari M; Maegel L; Müller M; Izykowski N; Hong J; Hong K; Kim SH; Dorsch M; Mahadeva R; Laenger F; Kreipe H; Braun A; Shahaf G; Lewis EC; Welte T; Dinarello CA; Janciauskiene S
    Proc Natl Acad Sci U S A; 2013 Sep; 110(37):15007-12. PubMed ID: 23975926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.